chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Adult couple was administered a booster dose of 0.25ml from the Pediatric Moderna vial NDC 80777-0279-05; Adult couple was administered a booster dose of 0.25ml from the Pediatric Moderna vial NDC 80777-0279-05; This spontaneous case was reported by a non-health professional and describes the occurrence of INCORRECT DOSE ADMINISTERED (Adult couple was administered a booster dose of 0.25ml from the Pediatric Moderna vial NDC 80777-0279-05) and UNDERDOSE (Adult couple was administered a booster dose of 0.25ml from the Pediatric Moderna vial NDC 80777-0279-05) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (Adult couple was administered a booster dose of 0.25ml from the Pediatric Moderna vial NDC 80777-0279-05) and UNDERDOSE (Adult couple was administered a booster dose of 0.25ml from the Pediatric Moderna vial NDC 80777-0279-05). At the time of the report, INCORRECT DOSE ADMINISTERED (Adult couple was administered a booster dose of 0.25ml from the Pediatric Moderna vial NDC 80777-0279-05) and UNDERDOSE (Adult couple was administered a booster dose of 0.25ml from the Pediatric Moderna vial NDC 80777-0279-05) outcome was unknown.            No concomitant medication was reported by reporter.  Patient got booster dose.  No treatment medication was reported by reporter.
Recurrence of the exact symptoms I had when I had COVID in March, 2020, but less intense and for only one day.  These were severe fatigue and wet cough.  No fever. It was like deja vu, but only lasted 24 hours.  No other new symptoms.
No additional adverse effect reported.; M-M-R II, VAQTA and GARDASIL 9 that underwent a temperature excursion (case 01907249) were administered.; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's concurrent condition, pertinent medical history, concomitant medication, drug reactions or allergies were not reported.  On 09-FEB-2021, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) (lot #: T013204, expiration date: 03-DEC-2021 or lot #: T013546, expiration date: 28-OCT-2021 (two lot# of vaccines have been reported, no information of which one was administrated to the patient); dose, strength and route were not reported) for prophylaxis.          The vaccines underwent temperature excursions and were stored at 9 degree Celsius (C) to 25 C (8.7 C) for 30 minutes, 2 C to 8 C (8.2 C) for 30 minutes and 9 C to 25 C (9.43 C) for 45 minutes. There was no previous temperature excursion. The digital data logger was involved. No additional adverse effect reported.   This is one of 20 reports received from the same reporter. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T013546; expirationdate: 28-OCT-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2104USA002970: US-009507513-2104USA002944: US-009507513-2104USA002963: US-009507513-2104USA002972: US-009507513-2104USA002973: US-009507513-2104USA002974: US-009507513-2104USA002975: US-009507513-2104USA002976: US-009507513-2104USA002978: US-009507513-2104USA002980: US-009507513-2104USA002981: US-009507513-2104USA002982: US-009507513-2104USA002983: US-009507513-2104USA002984: US-009507513-2104USA002985: US-009507513-2104USA002986: US-009507513-2104USA002987: US-009507513-2104USA002988: US-009507513-2104USA002989:
The patient developed hives within 24 hours after receiving vaccines. The patient was treated with Benadryl. On 7/12/2001 the mother called and advised the patient's hives are worse.
Shortly after receiving immunizations, stood up and went to R/S appt. While in the hall, "felt sick" as if going to vomit. Face was pale. Was seated. Denied dizziness or lightheadedness, however, was unsteady on feet until seated. Had not eaten breakfast. Given orange juice and within a few minutes, returned to normal. No longer nauseated. Left to go home. Later in PM, mother called concerned that what happened was a "serum reaction" because his paper said pallor was a symptom to watch for. Son was fine now; riding dirt bike but even though reassurance, offered that son was fine and reaction was probably nervous reaction. She was not convinced.
20-YEAR-OLD FEMALE, REFERS THAT AT THE MOMENT SHE DOES NOT HAVE KNOWN ALLERGIES, NOR  SUFFER FROM MEDICAL CONDITIONS. AFTER THE INOCULATION THE PATIENT REFERS FEELING Dizzy AND NAUSED. PRESENTS 3 TO 4 VOMITS CONTINUOUSLY. VITAL SIGNS ARE MEASURED EVERY 15 MINUTES.
Note at this time, patient was currently 15 years of age. Per parent who is present, Mother , states,   I Mother  take full responsibility for allowing vaccination of a at 15 y.o. Noted his birthday.
Pfizer-BioNTech COVID-19 Vaccine EUA: During the administration of the vaccine, the vaccine leaker out. She was revaccinated immediately.
migraines; loss of taste; felt really hot/cold; right arm really sore; stomach problems; body is aching so bad, it hasn't stopped; headaches; joint hurt/now worse; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraines), AGEUSIA (loss of taste), FEELING OF BODY TEMPERATURE CHANGE (felt really hot/cold), PAIN IN EXTREMITY (right arm really sore) and ABDOMINAL DISCOMFORT (stomach problems) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Joint pain (Had joint pain prior to vaccine.).    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced ARTHRALGIA (joint hurt/now worse). On an unknown date, the patient experienced MIGRAINE (migraines), AGEUSIA (loss of taste), FEELING OF BODY TEMPERATURE CHANGE (felt really hot/cold), PAIN IN EXTREMITY (right arm really sore), ABDOMINAL DISCOMFORT (stomach problems), MYALGIA (body is aching so bad, it hasn't stopped) and HEADACHE (headaches). At the time of the report, MIGRAINE (migraines), AGEUSIA (loss of taste), FEELING OF BODY TEMPERATURE CHANGE (felt really hot/cold), PAIN IN EXTREMITY (right arm really sore), ABDOMINAL DISCOMFORT (stomach problems) and HEADACHE (headaches) outcome was unknown and MYALGIA (body is aching so bad, it hasn't stopped) and ARTHRALGIA (joint hurt/now worse) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient reported that her joint hurt. She has been experiencing migraines, headaches, loss of taste, felt hot/cold, body is aching so bad, it hasn't stopped. She states she is now using knee brace. She stated she had joint pain already prior to vaccine but is now worse. Migraine is killing her and her body is significantly sore. Patient stated her right arm was sore afterwards the shot.  Patient did not take any medications for her symptoms as she can't due to stomach problems.
Patient started with diarrhea and nausea on Friday which soon turned into depression, anxiety and panic attacks that she has never experienced before.  It is still ongoing and we are trying to treat her with alternative treatments such as supplements through a nutritionist and accupuncture.
Lot of rash on body; Itching; This is a spontaneous report from a contactable consumer (patient) reported that a patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration  on an unspecified date at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced lot of rash on body and itching both on an unspecified date with outcome of unknown.   Information on the lot/batch number has been requested.
This spontaneous report as received from a registered nurse refers to a patient of unknown gender. On 17-OCT-2014. 16 weeks and 4 days old patient was vaccinated with a first dose of ROTATEQ (lot number, expiration date, dose were not reported), oral. No adverse effects were reported. Additional information is not expected due to no consent for follow up.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient received BNT162b2 (BNT162B2), on 15Apr2021 as dose 1, single (Lot number: EW0161) at the age of 70 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Anemic" (ongoing), notes: has always been anemic.; "High blood pressure" (ongoing); "Allergies" (ongoing); "Multivitamin multimineral supplement" (unspecified if ongoing). Concomitant medication(s) included: AMLODIPINE taken for hypertension (ongoing); FEXOFENADINE HYDROCHLORIDE taken for hypersensitivity (ongoing); FLUTICASONE PROPIONATE taken for hypersensitivity (ongoing). The following information was reported: VACCINATION SITE MASS (non-serious), outcome "not recovered", described as "noticed a knot on her left arm where she had been administered those doses". Therapeutic measures were not taken as a result of vaccination site mass.  Additional information: The patient also received BNT162b2 (BNT162B2), on 03May2021 as dose 2, single (Lot number: EW0167) in left arm and received BNT162b2 (BNT162B2), on 03May2021 as dose 3 (booster), single (Lot number: FL3197) in left arm for covid-19 immunisation. It was reported that a knot on her left arm where the patient had been getting Pfizer Covid-19 Vaccines and booster doses. Caller clarified that the patient had received 3 doses of Pfizer Covid-19 Vaccine in total including the first two doses, and then the third dose which was her booster. All of those doses were administered into her left arm. The patient noticed a knot on her left arm where the patient had been administered those doses a couple of weeks ago, around beginning of Nov2022.The patient was going to go get the updated version of the vaccine booster, whatever it is, but then noticed this knot on her left arm so thought the patient should find out if its ok to get another dose with her having the knot on her left arm before doing that; There were no other conditions. There were no investigations.There were no relevant tests
rash on chest and arms itches .  Dr prescribed methylprednisolone 4 mg
Patient said arm was extremely sore; later in the evening on the day she received vaccine her arm became very red at injection site and extremely painful to touch. Patient claims she could not lift her arm at all. Saw MD on 12/27/13 for pain and received numbing cream and pain killers.
Acute Pericarditis. ER visit but not hospitalized. recovered after 3 weeks of scheduled NSAIDs
After the vaccine, I felt a dizzy and serious headache at about 1h. On the second day, I have chest pain for around 3 weeks and a heartbeat fast than normal which means I can feel my heartbeat and it like I can hear it sometimes.  I also can't breathe sometimes and have heart pain.  I will wake up due to my heart beating fast and chest pain at the night. Those symptoms last about one month.
Unconsolable for 8 hours after receiving the vaccine with a tactile fever for less than 24 hours
1.  2/3/2021, 5:40 PM, unable to speak or think clearly for about 3 hours, suspect Stroke #1 2.  2/21-22/2021, 10:30 PM to 3:30 AM, excruciatingly severe pain in the forehead, could not think   straight, confusion, suspect Stroke #2 3.  2/23/2021, 9:00 AM to Noon, Meeting with Tax Preparer and wife, could not think or follow along with the conversation, continued confusion 4.  2/25/2021, 6:00 to 9:00 PM, could not prepare report for work, could not type or think straight, continued confusion 5.  2/25/2021, 9:00 AM, went to my PCP, unable to think straight, unable to read, unable to prepare work report, the doctor advised take I take 2 weeks off  6.  2/27/2021, Noon, went to (Privacy) for lunch with wife, left face and left arm went numb, wife drove me to the Hospital, symptoms subsided, waited in parking lot for one hour, then went home 7.  2/28/2021, 11:00 AM, slight headache, attended Church on-line, preparing table on porch for lunch when I lost control of left arm and left leg which went limp, severe pain in head, wife and daughter put me in car and took me to the Hospital at 3:30 PM, was admitted to Hospital, 2 CAT Scans and 1 MRI completed, Diagnosed that I had one new/current Stroke and that I had had two prior strokes, dates undeterminable per doctor, Hospital 8.  3/25/2021, 3:00 PM, Left arm and left leg floppy, no control, face numb and burning, eyes burning, CAT Scan and MRI, diagnosed with TIA, started me on Plavix  9.  3/29/2021, about 11:30 PM, high blood pressure, 207/94, admitted to Hospital, given Labetalol via IV 10 MG-2 Times, Cardine Drip, Procardia, discharged about 3:00 PM on 3/31/2021, started Carvedilol and Nifedipine 10.  4/2/2021, 2:30 PM, same symptoms as on 3/25/2021, went to Hospital, transported to another hospital about 8:30 PM for further diagnoses, neck spasm and loss of control of arms during admission at 2nd hospital, diagnosed brain damage due to High Blood Pressure, discharged 4-4-2021 to PCP 11.  4/5/2021, 2:00 AM, went to the Hospital, High Blood Pressure, 185/85, numbness in face, pressure in head and left eye, Blood Pressure came down after 2.5 hours, discharged about 4:30 AM 12.  1/24/2022, 10:00 AM, left and right arms and legs went limp, admitted to the Hospital, diagnosed with 2 new Strokes, discharged 1/25/2022
Fever; body aches; migraine; chills; nausea    Missed 1 day of work
All over body rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (All over body rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (All over body rash). At the time of the report, RASH (All over body rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment was reported.
patient was inappropriately given a first dose of Pfizer when he is not yet 12 years of age
pain as a numbing sensation from the shoulder to her thumb; numbing sensation from the shoulder to her thumb; nerve pain; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number 9974P, expiry date 9th May 2022) for prophylaxis.   On 12th June 2020, the patient received the 2nd dose of Shingrix. In June 2020, less than 3 weeks after receiving Shingrix, the patient experienced pain in arm, numbness in hand and nerve pain. On an unknown date, the outcome of the pain in arm, numbness in hand and nerve pain were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, numbness in hand and nerve pain to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced pain as a numbing sensation from the shoulder to her thumb, like nerve pain.  The pain began after receiving dose two of Shingrix and had worsened since it began. Consented to follow up.
Pt stated that got dizzy after getting the 2nd COVID-19 vaccine. Pt denies history of hypertension and diabetes. Pt did not have breakfast and did not drink water prior to receiving vaccine. Pt was observed for 15 minutes and was given juice and water and reported doing well. Pt denies chest pain, shortness of breath and new onset of weakness and numbness. BP: 139/70, HR: 87. Stable, released from vaccination site.
Two days after my second covid vaccine I had severe pain in both upper arms. I was unable to lift my  arms above shoulder level. I also had weakness in both arms. The pain was worse in bed and I was  unable to lift my arms at all from my sides.  I saw Dr my fmaily doctor and was started on prednisone for 6 days. the pain subsided  and movement returned. After the 6 days the pain returned as before. I also saw a pain specialist and 2  more visits to Family Dr. I had a second round of prednisone for 2 weeks and pain subsided mostly but  has returned but not as bad after 2 weeks.  I had 5 sessions of PT that helped somewhat
This spontaneous report was received from a nurse practitioner via a company representative and refers to a 17 year old female patient. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. In 2018 (reported as "sometime last year"), the patient was vaccinated with the third dose of GARDASIL 9 (dose, route, lot number and expiration date were not reported) for routine vaccine. Since the patient received the third dose of GARDASIL 9, she had been getting recurrent aphthous stomatitis, which had not responded to Acyclovir. She also felt always sick and had had some "immune issues mimicking fibromyalgia". The outcome of aphthous ulcer, immune system disorder, malaise and fibromyalgia was not recovered. The patient's mother felt that these symptoms were due to GARDASIL 9. However, the reporter did not reported the causality between the events and GARDASIL 9.
2MAY91 pt fussy, elevated temp 105.2, reddened rt leg;
Fever, chills, aches, dizziness, weakness, headache, no appetite. Took Tylenol and Advil.
I was 5 weeks, 6 days pregnant at the time of the flu shot vaccination.  I had an ultrasound on 11/18/15 which demonstrated growth of only 6 weeks and 2 days, no fetal heartbeat.  Ultrasound on 11/25/15 confirmed previous findings.
Red rash that appeared exactly a week after the first dose of Moderna vaccine. It's not painful, warm to the touch and is somewhat itchy.
Patient stated that her arms were really itchy and then she said that her stomach hurt.  She then became very pale and we laid her down and then she vomited.  Her arms bilaterally then became very red and swollen and hot.
SIDE EFFECTS/ISSUES; This spontaneous report received from a consumer concerned multiple patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced side effects/issues. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of side effects/issues was not reported. This report was non-serious. This case, from the same reporter is linked.
The day after the patient received the vaccine, (less than 24 hours) he developed a fever that lasted for about 2 days.  Fever was 100.8 to 101 regularly.  Fever broke after 2 days. 3 days after the vaccine, in the evening hours, pt noticed a welty rash that developed on his ankles.  On day 4, the rash was worse and was around his ankles as well as his lower legs.  The rash was described as "welty" and not itchy or bothersome other than having a rash.  I advised the patient to take benadryl to help treat the rash and to seek medical attention if the rash became worse or if there was any difficulty breathing.
Patient presented as a walk in to today's clinic and was given his vaccine. When the vaccinator sent to sign the card, it was noted that the patient had just received his first dose 2 weeks ago.
Swelling at injection site (upper left arm) and swollen lymph nodes under left arm. Onset upon waking the day after the injection, lymph node pain lasted 5 days.
Patient was 17 years old at the time of vaccination.  Moderna's vaccine is for patients 18 and older. On 2/25/21 patient came back for second dose.  The error was caught at that time.  The patient received a second dose of Moderna, consistent with the CDC recommendation.
Coughing started two days after first vaccine.  Treated for pneumonia.  Four weeks later C T Scan showed pulmonary fibrosis.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 06-NOV-2015 the patient was vaccinated with VAQTA (lot # L002717, expiration date 02-JUN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Information has been received from a physician concerning an 18 month old male who on 1/13/2005 was vaccinated in the left thigh wit a first dose of varicella virus vaccine live (lot 649281/0656P). The physician reported that on 6/27/2005 the patient developed herpes zoster on the left T3 dermatome. The patient was seen on the office for a clinical exam. Subsequently the patient recovered. Additional information is not expected.
Pt was accidentally given the pediatric dosage of Moderna COVID-19 vaccine,  0.25ml = 25mcg. After review of CDC's, literature. Error was corrected by administering 0.25ml (25mcg) of Adult Moderna COVID -19 Vaccine on the same day so pt got a total of 0.5ml = 50mcg
Pt recv vax on 10/13/98; on same day pt exp pain &induration in area of vax
immed pallor, sweating, BP 80/50, heart rate 50, dizzy;given adrenalin 1:1000, 0.4ml SC;recovered almost as fast as incident;refused paramedic help;
Received Td on Monday 10/21/02. Received flu vaccine 10/25/02. Monday 10/28/02 noticed area of bumps and egg size swelling on left arm; sites of both injections. Area sore and hot to touch. Per patient, seen in ER and diagnosed with cellulitis 10/29/02. Put on antibiotic and better today 10/30/2002.
3 minutes after vaccine administration. looked more seizure like symptoms. she felted warm and lightheaded. blacked/ out/fainted but no changes. only history of fainting was 15 years  ago. no chnage in vision or shortness of breath reported. First time received covid 19 bivalent booster and flu vaccine together today. no other history of fainting in the past.
Day of injection:  lower abd discomfort progressing to feeling of urgency. During the night hrs urgency and frequency increased. Mid morning of day 1: increasing frequency, incontinence, fever of 101.4 F, considerable pain with urination.
Approximately 7 days after receiving first COVID 19 Vaccine dose, patient presents to clinic with rash on Trunk
Vaccinee "did not convert" following a series w/Engerix-B (dosing schedule 0, 1, 6).